Results 101 to 110 of about 2,679 (180)

2-(1,2,4-triazole-5-yl)-1,3,4-oxadiazole as a novel building block for energetic materials. [PDF]

Front Chem, 2022
Dong Z, Wu Z, Zhang Q, Xu Y, Lu GP.
europepmc   +1 more source

Pharmaceutical properties of novel 3-((diisopropylamino)methyl)-5-(4-((4-(dimethylamino) benzylidene) imino) phenyl)-1,3,4-oxadiazole-2(3 H)-thione. [PDF]

Sci Rep
Al-Azawi KF, Hasoon BA, Ismail RA, Rasool KH, Jabir MS, Shaker SS, Jawad KH, Abdula AM, Ghotekar S, Swelum AA.   +9 more
europepmc   +1 more source

Coumarin derivatives containing the 1,3,4 oxadiazole/thiadiazole moiety discovered as potential anti-tobacco mosaic virus agents. [PDF]

Mol Divers
Hu Y, Sun Z, Zeng W, Qiu Y, Xu Z, Zhang J, Feng G.   +6 more
europepmc   +1 more source

Design, Synthesis, In Vivo, and In Silico Evaluation of Benzothiazoles Bearing a 1,3,4-Oxadiazole Moiety as New Antiepileptic Agents. [PDF]

ACS Omega, 2023
Chauhan B, Kumar R, Salahuddin, Singh H, Afzal O, Altamimi ASA, Abdullah MM, Yar MS, Ahsan MJ, Kumar N, Yadav SK.   +10 more
europepmc   +1 more source

Mechanistic and Structural Insights on Difluoromethyl-1,3,4-oxadiazole Inhibitors of HDAC6. [PDF]

Int J Mol Sci
Cellupica E, Gaiassi A, Rocchio I, Rovelli G, Pomarico R, Sandrone G, Caprini G, Cordella P, Cukier C, Fossati G, Marchini M, Bebel A, Airoldi C, Palmioli A, Stevenazzi A, Steinkühler C, Vergani B.   +16 more
europepmc   +1 more source

Microwave-Assisted Synthesis and Characterization of Novel 1,3,4-Oxadiazole Derivatives and Evaluation of In Vitro Antimycobacterial Activity. [PDF]

Cureus
Devaraji M, Thanikachalam PV.
europepmc   +1 more source

Synthesis of designed new 1,3,4-oxadiazole functionalized pyrano [2,3-f] chromene derivatives and their antimicrobial activities. [PDF]

Heliyon
Alatawi K, Qarah AF, Alharbi H, Alisaac A, Abualnaja MM, Attar RMS, Alsoliemy A, El-Metwaly NM.   +7 more
europepmc   +1 more source

Retraction notice to "Synthesis, molecular docking study and anticancer activity of novel 1,3,4-oxadiazole derivatives as potential tubulin inhibitors" [Heliyon 9 (2023) e13460]. [PDF]

Heliyon
Yousef TA, Alhamzani AG, Abou-Krisha MM, Kanthimathi G, Raghu MS, Kumar KY, Prashanth MK, Jeon BH.   +7 more
europepmc   +1 more source

Design, synthesis, and apoptotic antiproliferative efficacy of new quinazoline/1,3,4-oxadiazole-2-thione derived EGFR/HER-2 dual inhibitors with anti-breast cancer activity. [PDF]

RSC Med Chem
Gomaa HAM, Shaker ME, Alzarea SI, Alsahli TG, Alanazi AS, Mohamed FAM, Alanazi MN, Abou-Zied HA, Abdelmoez A, Brase S, Youssif BGM, Maghraby MT.   +11 more
europepmc   +1 more source